A. Torosantucci et al., IDENTIFICATION OF A 65-KDA MANNOPROTEIN AS A MAIN TARGET OF HUMAN CELL-MEDIATED IMMUNE-RESPONSE TO CANDIDA-ALBICANS, The Journal of infectious diseases, 168(2), 1993, pp. 427-435
To identify molecular targets of anticandidal cell-mediated immunity (
CMI) in humans, a highly immunogenic mannoprotein fraction (MP-F2) of
Candida albicans was studied. SDS-PAGE and gel-permeation chromatograp
hy separated MP-F2 into polydisperse mannoproteins of >200-31.5 kDa. H
owever, only a 65-kDa constituent specifically induced proliferation o
f human peripheral blood mononuclear cells (PBMC). Lymphoproliferation
was accompanied by production of interleukin (IL)-1beta, interferon-g
amma, and IL-6 but not IL-4. MP-F2- and MP-65-induced PBMC proliferati
on was inhibited by an antagonist anti-T cell receptor antibody. Neith
er the purified protein derivative of Mycobacterium tuberculosis nor M
P-65 activated naive lymphocytes from umbilical cord blood, although t
hese cells proliferated extensively in response to both phytohemagglut
inin and IL-2. These data strongly suggest that MP-65 is an immunodomi
nant mannoprotein antigen that is ordinarily expressed as a target of
anti-Candida CMI in healthy humans.